How enforcement, settlement posture, and leverage change once the first generic or biosimilar has already entered the market.
Speaker(s):
Christian Hartmann
Senior Director, IP Solutions
RWS
Agenda Track No.:
Track 3
Session Type:
Break / Networking
Force Inline Description:
0